Although regular treatment with ACE inhibitors appears to be a factor associated with the development of HF, in this case, it may be acting as a confounding factor because it is a common treatment for patients with previous HF, nephropathy, or hypertension, which are risk factors for HF. The gene discussed is ACE; the disease is Nephropathy.